NDUFA4L2 mRNA expression level correlated with tumor stage and overall survival (Minton et al., 2016), and overexpression of NDUFA4L2 was also reported to associate with poor prognosis in ccRCC patients (Lv et al., 2016). The gene discussed is COXFA4L2; the disease is nonpapillary renal cell carcinoma.